Adipokines as a link between obesity and chronic kidney disease
about
Adipocytokines in renal transplant recipientsPresent and future in the treatment of diabetic kidney diseaseObesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesDietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data.Mechanisms by which heme oxygenase rescue renal dysfunction in obesity.Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.Effect of therapeutic plasma exchange on plasma levels and total removal of adipokines and inflammatory markers.Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis.The Protective Effects of Curcumin on Obesity-Related Glomerulopathy Are Associated with Inhibition of Wnt/β-Catenin Signaling Activation in Podocytes.Oxidative stress and autophagy: crucial modulators of kidney injuryThe dose-response effect of insulin sensitivity on albuminuria in children according to diabetes typeAdiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis.Evaluation of serum Resistin in children with chronic renal failure undergoing hemodialysis.Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.The relationship of serum adipokines with malnutrition inflammation score in haemodialysis.Association between serum resistin level and outcomes in kidney transplant recipients.Diet induced obesity in rats reduces NHE3 and Na(+) /K(+) -ATPase expression in the kidney.Resistin-Like Molecule Beta (RELM-β) Regulates Proliferation of Human Diabetic Nephropathy Mesangial Cells via Mitogen-Activated Protein Kinases (MAPK) Signaling Pathway.Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21?Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers.Obesity, hyperhomocysteinaemia and risk of chronic kidney disease: a population-based study.Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring.Long-term study of the association of adipokines and glucose variability with diabetic complications.Adipokines and their role in chronic kidney disease.Adipokine Profiling in Adult Women With Central Obesity and Hypertension.Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study
P2860
Q26747604-3D042DB0-B214-4A44-A8C0-6E899E6531D0Q26864133-AC15A04C-DE6C-4697-9ECD-F341760C25D0Q28088325-1CBEA0C2-4BF4-48B0-B47A-0F496FBA4080Q31157315-2A70A6C4-BBD4-4932-A2B2-F05143B43D1BQ34431848-93110664-9403-4F55-BE40-3A51C1910CFEQ35613320-32D6D4D7-9D28-4228-8160-F497AE0E68FCQ35794681-96483CD3-AC9E-4C3B-9176-A01B93743EE7Q35995651-016CBBE2-1B24-4D36-9B41-6FCFAD3B37E7Q36204477-229BAC23-A892-43F2-B619-B8ADB866BADFQ36717785-1084CB2B-0D72-4776-B0C1-DE02B54D882CQ36827355-EFB6B2CD-9525-4BFF-8C3C-4CB33FE3F63BQ36895502-4E1842B6-8C59-42B7-8C14-75BCC747539EQ36950161-B8233A78-A2CA-43F3-9C8C-BFFA21686F1CQ36958908-33EA9731-97BA-4085-864E-D1C2AEA56B08Q37238834-5ED8B9FA-18F9-4962-A109-AD3239B769EEQ37681996-0A3F1A15-6C28-4D2E-9822-8D34CDF848AAQ38198872-CD1E8674-4773-4BCB-97B0-DF1962FD082DQ40157356-CBDA6D2F-2C95-4AD6-942E-8E7C019058DAQ40240364-3DDB29D4-2E37-4D28-8603-436B54B558EEQ40738109-6341154C-2EE7-4E71-B39D-D3945B98C37DQ41475689-6556B244-2E83-4C0D-B42A-7D84605D6E6CQ42219850-431A03DE-A1DB-4E6F-A3AC-FCF0E6683313Q46712922-F2B7F3BF-1D5C-44E9-9E99-616DA9CEA034Q47593015-70C1C138-B74D-4190-A3B0-7A85C60283F7Q50898300-C85FB925-130D-4F2B-B4A2-A49A1E47A369Q53749188-293C5E2C-CC8E-4779-9E85-713B578FA26EQ53923968-B1835B07-936C-469E-A76B-821D6EE06EB3Q55548906-235E4795-5FC2-4276-876C-C5A669F37426Q58713912-79D26108-3182-4D74-A6F3-00E794BA850A
P2860
Adipokines as a link between obesity and chronic kidney disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adipokines as a link between obesity and chronic kidney disease
@ast
Adipokines as a link between obesity and chronic kidney disease
@en
Adipokines as a link between obesity and chronic kidney disease
@nl
type
label
Adipokines as a link between obesity and chronic kidney disease
@ast
Adipokines as a link between obesity and chronic kidney disease
@en
Adipokines as a link between obesity and chronic kidney disease
@nl
prefLabel
Adipokines as a link between obesity and chronic kidney disease
@ast
Adipokines as a link between obesity and chronic kidney disease
@en
Adipokines as a link between obesity and chronic kidney disease
@nl
P2860
P50
P3181
P1476
Adipokines as a link between obesity and chronic kidney disease
@en
P2093
Jessica F Briffa
P2860
P304
P3181
P356
10.1152/AJPRENAL.00263.2013
P407
P577
2013-12-15T00:00:00Z